Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1243-1245

  Martella, Vito ^a   Cavalli, Alessandra ^a   Decaro, Nicola ^a   Elia, Gabriella ^a   Desario, Costantina ^a   Campolo, Marco ^a   Bozzo, Giancarlo ^a   Tarsitano, Elvira ^a   Buonavoglia, Canio ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MATERNAL ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGENIC VARIATION; ARTICLE; CAT; CONTROLLED STUDY; DOG; FELIDAE; HOST RANGE; IMMUNOGENICITY; MINK; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; REVACCINATION; SEROCONVERSION; WOLF;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; DOGS; IMMUNIZATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; VIRAL VACCINES;

EID: 26944448893     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1243-1245.2005     Document Type: Article

References (42)

1. Appel, M. J. G., W. F. Scott, and L. E. Carmichael. 1979. Isolation and immunization studies of canine parvo-like virus from dogs with haemorrhagic enteritis. Vet. Rec. 105:156-159.
2. Buonavoglia, C., A. Cavalli, E. Gravino, V. Voigt, D. Buonavoglia, and D. de Capraris. 1994. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus. J. Vet. Med. B 41:3-8.
3. Buonavoglia, C., E. Tollis, D. Buonavoglia, and A. Puccini. 1992. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine. Comp. Immunol. Microbiol. Infect. Dis. 15:281-283.
4. Buonavoglia, C., M. Compagnucci, and Z. Orfei. 1983. Dog response to plaque variant of canine parvovirus. J. Vet. Med. B 30:526-531.
5. Buonavoglia, C., V. Martella, A. Pratelli, M. Tempesta, A. Cavalli, D. Buonavoglia, G. Bozzo, G. Elia, N. Decaro, and L. Carmichael. 2001. Evidence for evolution of canine parvovirus type 2 in Italy. J. Gen. Virol. 82:3021-3025.
6. Buonavoglia, D., A. Cavalli, A. Pratelli, V. Martella, G. Greco, M. Tempesta, and C. Buonavoglia. 2000. Antigenic analysis of canine parvovirus strains isolated in Italy. Microbiologica 23:93-96.
7. Burtonboy, G., F. Coignoul, P. P. Pastoret, and N. Delferriere. 1979. Canine hemorrhagic enteritis detection of viral particles by electron microscopy. Arch. Virol. 61:1-11.
8. Burtonboy, S., P. Charlier, J. Hertoghs, M. Lobmann, A. Wiseman, and S. Woode. 1991. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody. Vet. Rec. 128:377-381.
9. Carmichael, L. E. 1983. Immunization strategies in puppies-why failures? 32nd Symposium on Small Animal Pediatrics. Comp. Cont. Educ. Pract. Vet. 5:1043-1051.
10. Carmichael, L. E., and L. N. Binn. 1981. New enteric diseases in the dog. Adv. Vet. Sci. Comp. Med. 25:1-37.
11. Carmichael, L. E., J. C. Joubert, and R. V. H. Pollock. 1983. A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response. Cornell Vet. 71:408-427.
12. Carmichael, L. E., J. C. Joubert, and R. V. H. Pollock. 1983. A modified live canine parvovirus vaccine. II. Immune response. Cornell Vet. 73:13-29.
13. Decaro, N., M. Campolo, C. Desario, G. Elia, V. Martella, E. Lorusso, and C. Buonavoglia. Maternally-derived antibodies in pups and protection from canine parvovirus infection. Biologicals, in press.
14. De Ybanez, R. R., C. Vela, E. Cortes, I. Simarro, and J. I. Casal. 1995. Identification of types of canine parvovirus circulating in Spain. Vet. Rec. 136:174-175.
15. Greenwood, N. M., W. S. K. Chalmers, W. Baxendale, and H. Thompson. 1996. Comparison of isolates of canine parvovirus by monoclonal antibody and restriction enzyme analysis. Vet. Rec. 138:495-496.
16. Greenwood, N. M., W. S. K. Chalmers, W. Baxendale, and H. Thompson. 1995. Comparison of isolates of canine parvovirus by restriction enzyme analysis, and vaccine efficacy against field strains. Vet. Rec. 136:63-67.
17. Hoare, C. M., P. DeBouck, and A. Wiesman. 1997. Immunogenicity of a low-passage, high-liter modified live canine parvovirus vaccine in pups with maternally derived antibodies. Vaccine 15:273-275.
18. Hueffer, K., J. S. L. Parker, W. Weichert, R. E. Geisel, J.-Y. Sgro, and C. R. Parrish. 2003. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J. Virol. 77:1718-1726.
19. Ikeda, Y., M. Mochizuki, R. Naito, K. Nakamura, T. Myazawa, T. Mikami, and E. Takahashi. 2000. Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology 278:13-19.
20. Johnson, R. H., and P. B. Spradbrow. 1979. Isolation from dogs with severe enteritis of a parvovirus related to feline panleukopaenia virus. Aust. Vet. J. 55:151.
21. Kelly, W. R. 1978. An enteric disease of dogs resembling feline panleukopaenia virus. Aust. Vet. J. 54:593.
22. Martella, V., A. Cavalli, A. Pratelli, G. Bozzo, M. Camero, D. Buonavoglia, D. Narcisi, M. Tempesta, and C. Buonavoglia. 2004. A canine parvovirus mutant is spreading in Italy. J. Clin. Microbiol. 42:1333-1336.
23. Mochizuki, M., R. Harasawa, and H. Nakatani. 1993. Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan. Vet. Microbiol. 38:1-10.
24. Nakamura, M., Y. Tohya, T. Miyazawa, M. Mochizuki, H. T. Phung, N. H. Nguyen, L. M. Huynh, L. T. Nguyen, P. N. Nguyen, P. V. Nguyen, N. P. Nguyen, and H. Akashi. 2004. A novel antigenic variant of canine parvovirus from a Vietnamese dog. Arch. Virol. 149:2261-2269.
25. Parker, J. S. L., W. J. Murphy, D. Wang, S. J. O'Brien, and C. R. Parrish. 2001. Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J. Virol. 75:3896-3902.
26. Parrish, C. R. 1999. Host range relationships and the evolution of canine parvovirus. Vet. Microbiol. 69:29-40.
27. Parrish, C. R., C. F. Aquadro, M. L. Strassheim, J. F. Evermann, J.-Y. Sgro, and H. O. Mohammed. 1991. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J. Virol. 65:6544-6552.
28. Parrish, C. R., P. H. O'Connell, J. F. Evermann, and L. E. Carmichael. 1985. Natural variation of canine parvovirus. Science 230:1046-1048.
29. Pereira, C. A., T. A. Monezi, D. U. Mehnert, M. D'Angelo, and E. L. Durigon. 2000. Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay. Vet. Microbiol. 75:127-133.
30. Pollock, R. V., and L. E. Carmichael. 1983. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus. Am. J. Vet. Res. 44:169-175.
31. Pollock, R. V. H., and L. E. Carmichael. 1982. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J. Am. Vet. Med. Assoc. 180:37-42.
32. Pratelli, A., A. Cavalli, G. Normanno, M. G. De Palma, G. Pastorelli, V. Martella, and C. Buonavoglia. 2000. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b). J. Vet. Med. B 47:373-376.
33. Pratelli, A., A. Cavalli, V. Martella, M. Tempesta, N. Decaro, L. E. Carmichael, and C. Buonavoglia. 2001. Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin. Diagn. Lab. Immunol. 8:612-615.
34. Sagazio, P., M. Tempesta, D. Buonavoglia, F. Cirone, and C. Buonavoglia. 1998. Antigenic characterization of canine parvovirus strains isolated in Italy. J. Virol. Methods 73:197-200.
35. Steinel, A., C. R. Parrish, M. E. Bloom, and U. Truyen. 2001. Parvovirus infections in wild carnivores. J. Wildl. Dis. 37:594-607.
36. Steinel, A., E. H. Venter, M. Van Vuuren, C. R. Parrish, and U. Truyen. 1998. Antigenic and genetic analysis of canine parvoviruses in southern Africa. Onderstepoort J. Vet. Res. 65:239-242.
37. Truyen, U., A. Gruenberg, S.-F. Chang, B. Obermaier, P. Veijalainen, and C. R. Parrish. 1995. Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J. Virol. 69:4702-4710.
38. Truyen, U., A. Steinel, L. Bruckner, H. Lutz, and K. Mostl. 2000. Distribution of antigen types of canine parvovirus in Switzerland, Austria and Germany. Schweiz. Arch. Tierheilkd. 142:115-119.
39. Truyen, U., and C. R. Parrish. 1992. Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. J. Virol. 66:5399-5408.
40. Truyen, U., G. Platzer, and C. R. Parrish. 1996. Antigenic type distribution among canine parvoviruses in dogs and cats in Germany. Vet. Rec. 138:365-366.
41. Truyen, U., J. F. Evermann, E. Vieler, and C. R. Parrish. 1996. Evolution of canine parvovirus involved loss and gain of feline host range. Virology 215:186-189.
42. Yule, T. D., M. B. Roth, K. Dreier, A. F. Johnson, M. Palmer-Densmore, K. Simmons, and R. Fanton. 1997. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine 15:720-729.